glp-1 receptor agonists cardiovascular benefits for health In patients with #obesity, incretin-based

Diabetologia, In Press, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar] 25.Koehler JA, Baggio LL, Lamont BJ, Ali S, Drucker DJ

Journal Diabetes Research 2018 , Hou, Y., Ernst, S

In a large Phase 3 clinical trial published in the New England Journal of Medicine, people who took the highest dose of the Wegovy pill lost an average of 16.6 percent of their body weight after 64 weeks

Of the currently available classes of glucose-lowering therapies, the glucagonlike peptide-1 (GLP-1) receptor agonist class of medications has gained popularity in recent years

& Becker, C

[DOI] [PubMed] [Google Scholar] 49.Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis